Back to top
more

Chemed (CHE)

(Delayed Data from NYSE)

$577.66 USD

577.66
51,784

-0.13 (-0.02%)

Updated Sep 18, 2024 04:00 PM ET

After-Market: $565.05 -12.61 (-2.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (49 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Nalak Das headshot

Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results

Economic activities came almost to a standstill in March. However, one sector that witnessed heightening activities is health care.

Can TAVR's SAPIEN 3 Aid Edwards Lifesciences (EW) Q1 Earnings?

Robust customer adoption of the HemoSphere all-in-one monitoring platform and TAVR treatments is likely to have driven Edwards Lifesciences' (EW) Q1 revenues.

Will Coronavirus Test Aid Thermo Fisher's (TMO) Q1 Earnings?

Thermo Fisher (TMO) successfully attains EUA from the FDA as well as receives the CE Mark in Europe for its COVID-19 diagnostic test.

Intuitive Surgical (ISRG) Q1 Earnings Beat Estimates, Up Y/Y

Intuitive Surgical (ISRG) first-quarter results benefit from strong growth across all businesses and higher revenues.

Bet on These 5 Low Leverage Stocks as Q1 Earnings Starts

To safeguard one's portfolio from notable losses, the real challenge for an investor is determining whether the organization's debt level is sustainable. A debt-free corporation is hard to find.

Abbott (ABT) Beats on Q1 Earnings, Suspends '20 Guidance

Uncertainties about the duration and impact of the coronavirus pandemic on its overall business compel Abbott (ABT) to suspend its full-year guidance.

Tirthankar Chakraborty headshot

New Strong Buy Stocks For April 16th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

What's in Store for Intuitive Surgical (ISRG) Q1 Earnings?

Intuitive Surgical's (ISRG) Q1 earnings are likely to reflect better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth.

Will COVID-19 Test Aid Quest Diagnostics (DGX) Q1 Earnings?

Quest Diagnostics' (DGX) recently-launched COVID-19 test service anticipated to have contributed to Q1 revenues.

Will Brand Building Efforts Aid Aphria (APHA) in Q3 Earnings?

Aphria's (APHA) focus on enhancing its brands and profitability is likely to have boosted its top line in third-quarter fiscal 2020.

Solid Diagnostics to Aid Abbott (ABT) Q1 Earnings Amid Crisis?

Though the magnitude of loss due to the virus outbreak in Abbott's (ABT) Core Laboratory business is still unclear, the company's point-of-care business is anticipated to generate profit.

The Zacks Analyst Blog Highlights: Koninklijke Philips, Dropbox, Cardinal Health, Enphase Energy and Chemed

The Zacks Analyst Blog Highlights: Koninklijke Philips, Dropbox, Cardinal Health, Enphase Energy and Chemed

Can Product Innovation Aid OrganiGram (OGI) in Q2 Earnings?

OrganiGram (OGI) is expected to have benefited from its focus on building brand equity and ongoing product innovation in the fiscal second quarter.

Will Low Product Revenues Impact Abbott (ABT) Q1 Earnings?

Revenues of Abbott's (ABT) Diabetes Care business, which has been, otherwise on a strong growth trajectory, are likely to have declined in Q1 due to the coronavirus-related market turbulence.

Nalak Das headshot

U.S. Economy Likely to Reopen in May: 5 Top Growth Picks

Although the death toll continues to go up in the United States, the curves related to hospitalization, intensive-care check-ins and intubations are gradually flattening.

Why the Earnings Surprise Streak Could Continue for Chemed (CHE)

Chemed (CHE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Chemed (CHE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Chemed (CHE) Outperforming Other Medical Stocks This Year?

Is (CHE) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: A10 Networks, Chemed, Core-Mark, Eli Lilly and Masimo

The Zacks Analyst Blog Highlights: A10 Networks, Chemed, Core-Mark, Eli Lilly and Masimo

Tirthankar Chakraborty headshot

New Strong Buy Stocks for April 9th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Tirthankar Chakraborty headshot

5 Low-Risk Stocks to Buy for Epic Price Swings Since 1929

The S&P 500's average daily percentage price change over the past five weeks has been plus or minus 4.8%. This explains why the Cboe Volatility Index remains elevated at around the 40s.

Nalak Das headshot

Market to Stay Northbound Despite Volatility: 5 Growth Picks

Although, short-term fluctuations will continue on account of the coronavirus-induced crisis, overall market movement will remain positively sloped.

Catasys (CATS) Looks Good: Stock Adds 9.2% in Session

Catasys (CATS) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Buy These 5 Low Leverage Stocks Amid Coronavirus-Led Sell Off

This is a good time to go for safe stocks so that in the event of any further market turmoil the stockholders do not lose significantly. Stocks with low debt-to-equity ratio offer that safety.